
TRIPLEPOINT VENTURE GROWTH B
TPVGNYSETrading Snapshot
- Day Range
- $5.26 โ $5.34
- 52-Week Range
- $4.40 โ $6.95
- Volume
- $2.77B
- Avg Volume
- $2.69B
- Shares Outstanding
- 40.6M
- Next Earnings
- Oct 2, 2026
Fundamentals Snapshot
- Annual Revenue
- $97M
- Last Q Revenue
- $24M
- P/E Ratio
- 5.3
- P/S Ratio
- 2.0x
- EPS (TTM)
- $0.99
- Dividend Yield
- 17.02%
Why Investors Own TPVG
- โHigh-growth profile โ revenue up +26.4% YoY with expanding US Equity exposure.
- โHealthy economics โ 70% gross margin and 9% free-cash-flow margin.
- โNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About TRIPLEPOINT VENTURE GROWTH B
TriplePoint Venture Growth BDC Corp. (TPVG) functions as a business development company, primarily concentrating its investments on growth-stage enterprises backed by venture capital. The firm's core offering involves providing debt financing solutions to companies within the venture growth ecosystem. These solutions encompass a diverse range of products, such as growth capital loans, customized and secured credit facilities, equipment financing, and revolving lines of credit. Additionally, TPVG engages in direct equity investments. Its investment strategy targets companies operating in key sectors, including e-commerce, entertainment, technology, and life sciences. Within the technology sphere, the areas of specific interest are broad, covering cybersecurity, wireless communication equipment, network systems and software, business application software, conferencing solutions, big data analytics, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, various software categories (including Software-as-a-Service), and other related technological subsectors. For life sciences, TPVG focuses on biotechnology, biofuels/biomass, diagnostic testing and bioinformatics, drug delivery systems, drug discovery, healthcare information systems, healthcare services, medical/surgical/therapeutic devices, pharmaceuticals, and other related fields. The size of TPVG's investments varies based on the type of financing: growth capital loans typically range from $5 million to $50 million, equipment financings are between $5 million and $25 million, and revolving loans generally fall between $1 million and $25 million. Direct equity investments, conversely, are usually from $0.1 million to $5 million, and are structured to not exceed 5% of the portfolio company's total equity. The debt financing instruments are commonly structured as lines of credit, and the company also employs warrants and secured loans in its funding approach. TPVG aims to achieve targeted returns of 10% to 18%. A distinctive aspect of its investment policy is that it does not seek board representation in the companies it finances.
Otter Score Breakdown
โAnalyst Ratings
โLatest News & Updates

TriplePoint Venture Growth BDC Corp. 2026 Q2 - Results - Earnings Call Presentation
2026-08-09. The following slide deck was published by TriplePoint Venture Growth BDC Corp.

Insurers Went Bargain Hunting For BDC Bonds In Q1
Insurance companies did not shy away from securities of business development companies in the first quarter of 2026, despite broader market concerns over the quality of some BDC portfolios
Keefe, Bruyette & Woods Maintains Market Perform on TriplePoint Venture Gwth, Lowers Price Target to $5.5
Keefe, Bruyette & Woods analyst Paul Johnson maintains TriplePoint Venture Gwth (NYSE:TPVG) with a Market Perform and lowers the price target from $6 to $5.5.
TriplePoint Venture Growth (NYSE:TPVG) Edges Higher on Distributions and Revolut Gains Despite Q2 Earnings Miss
TPVG Q2 NII misses estimates, but shares rise on strong portfolio yield, supplemental distributions, and Revolut gains.

TriplePoint Venture Growth BDC Corp. (TPVG) Q2 2026 Earnings Call Transcript
TriplePoint Venture Growth BDC Corp. (TPVG) Q2 2026 Earnings Call August 5, 2026 5:00 PM EDTCompany ParticipantsJames Labe - Co-Founder, Chairman &...
TriplePoint Venture Gwth Q2 EPS $0.21, Inline, Sales $22.145M Miss $23.195M Estimate
TriplePoint Venture Gwth (NYSE:TPVG) reported quarterly earnings of $0.21 per share which met the analyst consensus estimate. This is a 25 percent decrease over earnings of $0.28 per share from the same period last